Decoding Immune Responses Together

Advancing Biomarkers and Target Discoveries

Novel high-throughput MIPSA technology provides the broadest antigen panels available to comprehensively map the individual antibody reactomes in your cohort. Our panels include all known viral and pathogen immune targets, autoantigens and allergens.

Sign up for our early access grant program to experience first-hand how Infinity Bio’s powerful technology can advance your research